Collision Tumors Involving Metastatic Carcinoma and Plasma Cell Myeloma: Report of Two Cases
Case Reports in Pathology · 2026-01 · 2026 (1)
DOI: 10.1155/crip/9279261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Case Reports in Pathology, online erschienen am 25.04.2026. Verfasst von Ahmed A Ahmed und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Synchronous coexistence of plasma cell neoplasms (PCNs) and metastatic carcinoma is not a common phenomenon and poses a significant diagnostic challenge requiring meticulous histopathological and immunophenotypic analysis for accurate lineage assignment. We report two cases of collision tumors comprising PCN and metastatic lung carcinoma. Case 1 involved a 68‐year‐old male with metastatic non–small cell lung adenocarcinoma who developed intracranial lesions; resection revealed metastatic adenocarcinoma intermingled with clonal plasma cells. Case 2 was a 73‐year‐old woman with a lytic iliac crest lesion whose bone marrow and lesion biopsies showed diffuse infiltration by both carcinoma and atypical plasma cells. Comprehensive immunohistochemical profiling, in situ hybridization (ISH), and molecular studies were performed. In both cases, histology demonstrated two distinct, intermingled cell populations without transitional features. IHC was critical for confirmation: the carcinoma cells expressed epithelial markers (AE1/AE3), whereas the plasma cell components were positive for CD138. ISH in Case 1 and flow cytometry in Case 2 confirmed clonality (kappa light‐chain restriction). The final diagnoses were collision tumors of metastatic non–small cell lung adenocarcinoma with synchronous PCN (Case 1) and metastatic small cell carcinoma with synchronous PCN (Case 2). There are sporadic reports of PCN coexistent in the same lesion with solid tumors. These cases reveal the critical role of the pathologist in diagnosing collision tumors. IHC panel, including cytokeratins, CD138, and MUM1, can help in distinguishing these dual populations and avoiding diagnostic pitfalls.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, University of Nebraska Medical Center, Omaha, Nebraska, USA, unmc.edu.
- Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas, USA, uth.edu.
ORCID-Profile: Ahmed A Ahmed, Xinhai Robert Zhang
Zitieren
APA
Ahmed, A. A., Khalid, M. H., Rehman, A. U., Nguyen, N. D., & Zhang, X. R. (2026). Collision Tumors Involving Metastatic Carcinoma and Plasma Cell Myeloma: Report of Two Cases. Case Reports in Pathology, 2026(1). https://doi.org/10.1155/crip/9279261
Vancouver
Ahmed AA, Khalid MH, Rehman AU, Nguyen ND, Zhang XR. Collision Tumors Involving Metastatic Carcinoma and Plasma Cell Myeloma: Report of Two Cases. Case Reports in Pathology. 2026;2026(1). doi:10.1155/crip/9279261
BibTeX
@article{Ahmed2026,
author = {Ahmed, Ahmed A and Khalid, Muhammad Hassaan and Rehman, Asad Ur and Nguyen, Nghia D and Zhang, Xinhai Robert},
title = {Collision Tumors Involving Metastatic Carcinoma and Plasma Cell Myeloma: Report of Two Cases},
journal = {Case Reports in Pathology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crip/9279261}
}
EUVIMED